Mostrar el registro sencillo del ítem
dc.contributor.author
Kempfer, Ana Catalina
dc.contributor.author
Paiva, J.
dc.contributor.author
Woods, Adriana Inés
dc.contributor.author
Nuñez, M.
dc.contributor.author
Ponteville, C.
dc.contributor.author
Casinelli, Maria Marta
dc.contributor.author
Lazzari, María Ángela
dc.contributor.author
Sánchez Luceros, Analía Gabriela
dc.date.available
2024-12-02T10:04:32Z
dc.date.issued
2019
dc.identifier.citation
ADAMTS13 Antigen together to collagen binding to von Willebrand Factor (VWF:CB) and VWF Antigen (VWF:Ag) were potential markers of acute disease severity in acquired thrombotic thrombocytopenic purpura (aTTP); XXVII Congress of the International Society on Thrombosis and Haemostasis; Melbourne; Australia; 2019; 1-2
dc.identifier.issn
2451-9456
dc.identifier.uri
http://hdl.handle.net/11336/249076
dc.description.abstract
Background : The reduced levels of circulating ADAMTS13 antigen (Ag), at first presentation in patients (P) with non- inhibitory antibodies (ab), appear to be a major determinant of disease severity in aTTP (Thomas, 2015). Lack of larger VWF multimers was strongly correlated with low VWF:CB/VWF:Ag and the ratio could be a marker of crisis severity aTTP (Lotta, 2011).Aims : To evaluate the relationship between ADAMTS13 parameters and other laboratory markers to the severity of aTTP crisis in 57P.Methods : ADAMTS13 activity, Ag, free IgG, IgM, IgA anti-ADAMTS13 ab, VWF:CB collagen type I, VWF:Ag were evaluated (ELISA). Detection of circulating immune complexes (CIC) was done by A) ELISA with mouse monoclonal ab anti- ADAMTS13 (ABCAM) and anti- human IgG- HRP and B) ADAMTS13Ag kit and anti- humanIgG- HRP. Assessment of von Willebrand multimers by normalized multimer ratio. Interquartile Range (IQR) was obtained using normal plasma. Other variables were reported: platelet count, hematocrit, hemoglobin, white blood cells, and blood group. Informed consent and ethical approval were obtained.Results : Some of our results were reported in Table I. In addition, P usually had their first aTTP episode between their 19 and 74 years. Prevalence of women was 82%. CIC median of positive P (n=10) was 0.52 (IQR, 0.51- 0.65)We verified normal distribution of CIC, VWF:CB, VWF:Ag, Hematocrit, VWF:CB/VWF:Ag, and normalized multimers, whereas ADAMTS13 Ag needed to be Ln- transformed. Correlations were showed in Table II.A multiple linear regression model was applied to generate a more precise estimate of parameters. The result was Ln (ADAMTS13Ag)=- 2.343+0.017VWF:CB- 0.012VWF:Ag.Conclusions : In our cohort, 25% of P tested positive CIC, therefore during aTTP crisis do not seem to be a biomarker of disease severity.We can predict a value of Ln ADAMTS13 Ag from the values of VWF:CB and VWF:Ag. These variables can be candidate markers of disease severity in aTTP as ADAMTS13 Ag is.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Wiley
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
VWD adquirido
dc.subject
anticuerpos
dc.subject.classification
Hematología
dc.subject.classification
Medicina Clínica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
ADAMTS13 Antigen together to collagen binding to von Willebrand Factor (VWF:CB) and VWF Antigen (VWF:Ag) were potential markers of acute disease severity in acquired thrombotic thrombocytopenic purpura (aTTP)
dc.type
info:eu-repo/semantics/publishedVersion
dc.type
info:eu-repo/semantics/conferenceObject
dc.type
info:ar-repo/semantics/documento de conferencia
dc.date.updated
2022-11-01T23:11:23Z
dc.journal.pagination
1-2
dc.journal.pais
Australia
dc.journal.ciudad
Melbourne
dc.description.fil
Fil: Kempfer, Ana Catalina. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex". Departamento de Hemostasia y Trombosis; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.description.fil
Fil: Paiva, J.. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex". Departamento de Hemostasia y Trombosis; Argentina
dc.description.fil
Fil: Woods, Adriana Inés. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina
dc.description.fil
Fil: Nuñez, M.. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina
dc.description.fil
Fil: Ponteville, C.. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina
dc.description.fil
Fil: Casinelli, Maria Marta. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex". Departamento de Hemostasia y Trombosis; Argentina
dc.description.fil
Fil: Lazzari, María Ángela. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina
dc.description.fil
Fil: Sánchez Luceros, Analía Gabriela. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/toc/24750379/2019/3/S1
dc.conicet.rol
Autor
dc.conicet.rol
Autor
dc.conicet.rol
Autor
dc.conicet.rol
Autor
dc.conicet.rol
Autor
dc.conicet.rol
Autor
dc.conicet.rol
Autor
dc.conicet.rol
Autor
dc.coverage
Internacional
dc.type.subtype
Congreso
dc.description.nombreEvento
XXVII Congress of the International Society on Thrombosis and Haemostasis
dc.date.evento
2019-07-06
dc.description.ciudadEvento
Melbourne
dc.description.paisEvento
Australia
dc.type.publicacion
Journal
dc.description.institucionOrganizadora
International Society on Thrombosis and Haemostasis
dc.source.revista
Research Practice on Thrombosis and Haemostasis
dc.date.eventoHasta
2019-07-10
dc.type
Congreso
Archivos asociados